<DOC>
	<DOCNO>NCT02888496</DOCNO>
	<brief_summary>Pathophysiology polymyalgia rheumatica ( PMR ) ill define . This study aim characterize immunological abnormality PMR patient , assess effect tocilizumab therapy abnormality .</brief_summary>
	<brief_title>Lymphocyte Cytokine Disturbances Polymyalgia Rheumatica</brief_title>
	<detailed_description>Comparison PMR patient match control subject .</detailed_description>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<criteria>PMR patient include TENOR study sample available Patient include TENOR study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>